Arginyl-alpha-asparty -lyzyl, plunged-tyrosyl-arginine | Imunofan nasal spray 45 mcg / dose vial of 40 doses

Latin name

IMUNOFAN

release form

Nasal spray dosed clear, or slightly opalescent, colorless, or slightly yellowish liquid. A slight specific odor is allowed.

Packaging

In a plastic bottle with a dispensing device 8.5 ml in a pack of cardboard 1 bottle.

Indications

Prevention and treatment in adults and children over two years of age: Immunodeficiency and toxic conditions.

Chronic inflammatory diseases of various etiologies.

Contraindications

Hypersensitivity

Pregnancy complicated by rhesus conflict

Children under 2 years of age.

Use during pregnancy and lactation

Due to insufficient knowledge, it should be used with caution during pregnancy and lactation.

Composition

1 dose

immunofan 50 mcg

excipients: sodium chloride benzalkonium chloride glycine sodium edetate (trilon B) purified water

Dosage and Administration

Intranasally.

When using the bottle, keep it upright, spray up.

Remove the protective cap from the spray gun.

Before first use, fill the metering pump by pressing the wide bezel of the sprayer 3-4 times.

Insert the nebulizer into the nasal passage with the head upright.

Press the wide bezel of the spray gun once as far as it will go.

1 dose of the drug contains 50 mcg of immunofan. The daily dose should not exceed 200 mcg.

In the complex treatment of acute and chronic infectious and inflammatory diseases accompanied by symptoms of intoxication and immunodeficiency

Assign 1 dose (50 mcg) in each nasal passage 2 times a day, daily for 10-15 days.

For opportunistic infections (cytomegalovirus and herpetic infections, toxoplasmosis, chlamydia, pneumocystosis, cryptosporidiosis)

1 dose (50 mcg) in each nasal passage 2 times a day, daily, treatment 10-15 days. If necessary, the course may be repeated after 2-4 weeks.

In case of chronic viral hepatitis and chronic brucellosis

1 dose (50 mcg) in each nasal passage 1 time per day, daily, treatment course 10-15 days, to prevent relapse, repeated courses should be taken after 4-6 months.

In the treatment regimen for HIV-infected patients

1 dose (50 mcg) in each nasal passage 1 time per day, daily, for 10-15 days. If necessary, the course may be repeated after 2-4 weeks.

In the treatment of cancer patients in a radical combined treatment regimen (chemo-radiation therapy and surgery)

1 dose (50 mcg) in each nasal passage 1 time per day, daily,ia and surgery followed by the continuation of the course throughout the entire period of treatment.

In patients with a widespread tumor process (stage III-IV) of different localization in terms of complex or symptomatic therapy

1 dose (50 mcg) in each nasal passage 1 time per day, daily, for 8-10 days. If necessary and the presence of pronounced phenomena of toxicosis, a repeated course is recommended.

Side effects

Possibly: individual intolerance, allergic reactions.

Storage conditions

The product is stored in a dark place at 2 РC to 10 РC, out of the reach of children. It is not recommended to use the product after the expiry date stated on the package.

Shelf life

2 years.

Active ingredient

Arginyl-alpha-aspartyl-lysyl-valyl-tyrosyl-arginine

Terms and conditions

prescription

dosage form

nasal spray

Possible product names

IMUNOFAN 50MKG / DOSE 40DOSE FLAK SPRAY NASAL

Imunofan 50mkg / dose Spray nasal dosing. 40 doses Fl. layer. X1 B M

IMUNOFAN SPRAY NAZ. 500MKG / ML 40DOZ

IMUNOFAN SPRAY NAZ. 50MKG / DOSE FL. 40DOSE

Imunofan nasal spray 50 mcg / dose, 40 doses

Bionoks, Russia